These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 21660940)
1. Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells. Anderson BE; Tang AL; Wang Y; Froicu M; Rothstein D; McNiff JM; Jain D; Demetris AJ; Farber DL; Shlomchik WD; Shlomchik MJ Eur J Immunol; 2011 Sep; 41(9):2782-92. PubMed ID: 21660940 [TBL] [Abstract][Full Text] [Related]
2. Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice. Zhang P; Wu J; Deoliveira D; Chao NJ; Chen BJ Biol Blood Marrow Transplant; 2012 Oct; 18(10):1488-99. PubMed ID: 22809867 [TBL] [Abstract][Full Text] [Related]
3. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Johnson BD; Becker EE; Truitt RL Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958 [TBL] [Abstract][Full Text] [Related]
4. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935 [TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Zheng H; Matte-Martone C; Li H; Anderson BE; Venketesan S; Sheng Tan H; Jain D; McNiff J; Shlomchik WD Blood; 2008 Feb; 111(4):2476-84. PubMed ID: 18045967 [TBL] [Abstract][Full Text] [Related]
7. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Jones SC; Murphy GF; Korngold R Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217 [TBL] [Abstract][Full Text] [Related]
8. Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. Anderson BE; Taylor PA; McNiff JM; Jain D; Demetris AJ; Panoskaltsis-Mortari A; Ager A; Blazar BR; Shlomchik WD; Shlomchik MJ Blood; 2008 May; 111(10):5242-51. PubMed ID: 18285547 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice. Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159 [TBL] [Abstract][Full Text] [Related]
11. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Fowler DH; Gress RE Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects. Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558 [TBL] [Abstract][Full Text] [Related]
14. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519 [TBL] [Abstract][Full Text] [Related]
15. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL. Matte-Martone C; Liu J; Jain D; McNiff J; Shlomchik WD Blood; 2008 Apr; 111(7):3884-92. PubMed ID: 18223170 [TBL] [Abstract][Full Text] [Related]
16. Memory CD4+ T cells do not induce graft-versus-host disease. Anderson BE; McNiff J; Yan J; Doyle H; Mamula M; Shlomchik MJ; Shlomchik WD J Clin Invest; 2003 Jul; 112(1):101-8. PubMed ID: 12840064 [TBL] [Abstract][Full Text] [Related]
17. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II. van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF Front Immunol; 2018; 9():3016. PubMed ID: 30619360 [TBL] [Abstract][Full Text] [Related]
18. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells. Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201 [TBL] [Abstract][Full Text] [Related]
19. New developments in allotransplant immunology. Barrett AJ; Rezvani K; Solomon S; Dickinson AM; Wang XN; Stark G; Cullup H; Jarvis M; Middleton PG; Chao N Hematology Am Soc Hematol Educ Program; 2003; ():350-71. PubMed ID: 14633790 [TBL] [Abstract][Full Text] [Related]
20. "Pruning" of alloreactive CD4+ T cells using 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester prolongs skin allograft survival. Watson D; Zhang GY; Sartor M; Alexander SI J Immunol; 2004 Dec; 173(11):6574-82. PubMed ID: 15557147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]